| 1 |
Rider AC, Frazee BW. Community-acquired pneumonia[J]. Emerg Med Clin North Am, 2018, 36(4): 665-683.
|
| 2 |
Ferreira-Coimbra J, Sarda C, Rello J. Burden of community-acquired pneumonia and unmet clinical needs[J]. Adv Ther, 2020, 37(4): 1302-1318.
|
| 3 |
陈志海，周维华. 社区获得性肺炎患者病情严重度与降钙素原水平的相关性分析[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(3): 337-338.
|
| 4 |
Zhang Y, Zhu Y, Gao G, et al. Knockdown XIST alleviates LPS-induced WI-38 cell apoptosis and inflammation injury via targeting miR-370-3p/TLR4 in acute pneumonia[J]. Cell Biochem Funct, 2019, 37(5): 348-358.
|
| 5 |
Shan MR, Zhou SN, Fu CN, et al. Vitamin B6 inhibits macrophage activation to prevent lipopolysaccharide-induced acute pneumonia in mice[J]. J Cell Mol Med, 2020, 24(5): 3139-3148.
|
| 6 |
Karakioulaki M, Stolz D. Biomarkers in pneumonia-beyond procalcitonin [J]. Int J Mol Sci, 2019, 20(8): 2004.
|
| 7 |
江颖仪，李德宪，劳穗华，等. 血清淀粉样蛋白A、降钙素原、超敏C反应蛋白检测对肺结核合并肺炎的诊断价值[J]. 南方医科大学学报，2021, 41(3): 453-458.
|
| 8 |
叶舒婷，赵敏华，李梦远，等. 血清CTGF和PDGF-BB表达与老年特发性间质性肺炎相关性分析[J]. 浙江中西医结合杂志，2020, 30(11): 888-890.
|
| 9 |
李顺昌. sTREM-1、KL-6、PDGF联合检测在儿童病毒性肺炎早期鉴别及预后评估中的价值[J]. 中国妇幼保健，2020, 35(12): 2271-2274.
|
| 10 |
中华医学会呼吸病学分会. 社区获得性肺炎诊断和治疗指南[J]. 中国实用乡村医生杂志，2013, 20(2): 11-15.
|
| 11 |
马 慧，陈复辉. 多重病因下细菌和病毒双重感染性肺炎病毒相关病原学诊断的研究进展[J]. 医学综述，2021, 27(1): 63-66.
|
| 12 |
Moberg AB, Kling M, Paues J, et al. Use of chest X-ray in the assessment of community acquired pneumonia in primary care-an intervention study[J]. Scand J Prim Health Care, 2020, 38(3): 323-329.
|
| 13 |
Garin N, Marti C, Scheffler M, et al. Computed tomography scan contribution to the diagnosis of community-acquired pneumonia[J]. Curr Opin Pulm Med, 2019, 25(3): 242-248.
|
| 14 |
Ranzani OT, Coelho L, Torres A. Biomarkers in community-acquired pneumonia: can we do better by using them correctly？[J]. J Bras Pneumol, 2019, 45(4): e20190189.
|
| 15 |
杨桂虹. 降钙素原、C反应蛋白及WBC对老年社区获得性肺炎的诊断价值[J]. 中国急救医学，2018, 38(z1): 189.
|
| 16 |
李 杰. 血清YKL-40、全血WBC水平联合检测在婴幼儿社区获得性肺炎中的诊断价值分析[J]. 包头医学院学报，2020, 36(2): 77-78.
|
| 17 |
Giordano NP, Cian MB, Dalebroux ZD. Outer membrane lipid secretion and the innate immune response to gram-negative bacteria[J]. Infect Immun, 2020, 88(7): e00920-009219.
|
| 18 |
Florin TA, Ambroggio L, Brokamp C, et al. Biomarkers and disease severity in children with community-acquired pneumonia[J]. Pediatrics, 2020, 145(6): e20193728.
|
| 19 |
Kanaan R, Strange C. Use of multitarget tyrosine kinase inhibitors to attenuate platelet-derived growth factor signalling in lung disease[J]. Eur Respir Rev, 2017, 26(146): 170061.
|
| 20 |
McGowan SE, Lansakara TI, McCoy DM, et al. Platelet-derived growth factor-alpha and neuropilin-1 mediate lung fibroblast response to rigid collagen fibers[J]. Am J Respir Cell Mol Biol, 2020, 62(4): 454-465.
|
| 21 |
刘 萌，窦云鹏，谷 丽，等. 鉴别诊断临床急性肺炎病原体感染的血清标志物研究[J]. 首都医科大学学报，2016, 37(5): 636-640.
|
| 22 |
刘 欢，朱述阳，于海容，等. CRP、PCT、WBC联合检测对中老年社区获得性肺炎的诊断效果[J]. 现代生物医学进展，2020, 20(11): 2094-2097.
|
| 23 |
李 霞，邢 江，李 娟. N末端脑钠肽前体、降钙素原联合评分对老年社区获得性肺炎患者的生存价值分析[J]. 中国临床医生杂志，2020, 48(9): 1053-1055.
|
| 24 |
Kubicek-Sutherland JZ, Vu DM, Noormohamed A, et al. Direct detection of bacteremia by exploiting host-pathogen interactions of lipoteichoic acid and lipopolysaccharide[J]. Sci Rep, 2019, 9(1): 6203.
|
| 25 |
Wussler D, Kozhuharov N, Tavares OM, et al. Clinical utility of procalcitonin in the diagnosis of pneumonia[J]. Clin Chem, 2019, 65(12): 1532-1542.
|
| 26 |
肖伟利，王海超，裴复阳，等. TGF-β1、PDGF、VEGF评估吡非尼酮治疗特发性肺纤维化的临床疗效观察[J]. 临床肺科杂志，2020, 25(2): 209-213.
|
| 27 |
贺新伟，骆琼珍，赵丽丽，等. 成人社区获得性肺炎患者血清可溶性程序性死亡受体配体-1的表达及意义[J]. 中华内科杂志，2021, 60(3): 243-246.
|
| 28 |
Thomas J, Pociute A, Kevalas R, et al. Blood biomarkers differentiating viral versus bacterial pneumonia aetiology: a literature review[J]. Ital J Pediatr, 2020, 46(1): 4.
|
| 29 |
刘守娟，方喜波，王志华，等. 小儿肺炎不同感染病原体类型外周血WBC和血清CRP、PCT水平特点及其相关性研究[J]. 临床和实验医学杂志，2021, 20(6): 667-670.
|
| 30 |
任艳玲，刘 芳，王 静. 肺炎患者血清LTB4、ADA、内毒素水平变化及其病原体鉴别诊断价值分析[J]. 山东医药，2020,60(17):49-51.
|